Despite recent claims that “free trade is dead,” fellow Simon Lester explains that America was never close to anything resembling free trade in the first place. Instead, current U.S. trade policy, just like past policy, reflects a messy mix of free market and industrial policy views.
Drug companies that bypass distributors and offer generics directly to patients, like the Mark Cuban Cost Plus Drug Company, could disrupt the pharmaceutical supply chain and ultimately save thousands of lives.
As false or inaccurate information about stem cell interventions continues to circulate widely, the authors write that immediate action is needed to improve patient education and safety — and to combat misinformation more broadly.
With the recent enactment of the CHIPS and Science Act, the conversation about industrial policy has started up again. Are state-directed economic policies back, and will such initiatives work?
Though the OPEC+ group has agreed to accelerate planned oil production increases, the move will likely do little to reduce prices at the pump, despite a major U.S. concession, writes author Mark Finley — and Russia appears to support the plan. Read more on the Baker Institute Blog.
This article originally appeared in the Forbes blog on June 6, 2022.